Philip SEIB

[vc_row][vc_column][vc_row_inner][vc_column_inner][vc_single_image image=”1003″ img_size=”medium” alignment=”center” style=”vc_box_rounded” css_animation=”fadeInDown”][vc_column_text][/vc_column_text][/vc_column_inner][/vc_row_inner][vc_column_text]

Dr Philipp Seib obtained my BPharm and MSc from King’s College London and my PhD in drug delivery from Cardiff University before undertaking postdoctoral research at the Technical University Dresden (Germany) and Tufts University (Boston, USA). In 2012, he moved to the Strathclyde Institute of Pharmacy and Biomedical Sciences where he is currently a Reader in Pharmaceutical Materials.


Assembling silk into healthcare materials

Silk is an important biopolymer for biomedical applications because of its unique and highly versatile structure and its robust clinical track record in human medicine. Silk can be processed into many material formats, including physically and chemically cross-linked hydrogels, nanoparticles and scaffolds that have almost limitless applications ranging from tissue engineering to biomedical imaging and sensing. This presentation provides a background of silk and will cover drug and stem cell delivery using selected silk formats and processing.